ALEXANDER IVACHTCHENKO, Prof., DSc.
Chief Scientific Officer, Founder
Dr. Ivashchenko holds Doctor of Sciences (1982) and Professor (1988) degrees. He is the Distinguished Inventor of the Russian Federation (1984), the winner of the State Prize of the USSR (1983) and the Prize of the Council of Ministers of the USSR (1989).Dr. Ivashchenko is a world-recognized expert in the field of medicinal chemistry. He has been instrumental in advancing and supervising a series of studies on the development of innovative drugs for the treatment of cancer, hepatitis C, influenza, Alzheimer’s disease, schizophrenia and obesity. Many of these studies are currently at the clinical stage. Dr. Ivashchenko is a co-author of over 750 scientific publications and patents.Alex V. Ivashchenko (born March 24, 1945) is a founder and CSO of Chemical Diversity Research Institute (CDRI) of the Center of High Technologies “ChemRar” (Khimki, Moscow region), ChemDiv Inc. (USA), AllaChem LLC (USA), Avineuro Pharmaceuticals (USA).
RONALD DEMUTH, B.S., C.R.A. Senior VP, Corporate Development & General Manager
Prior to joining ChemDiv, Mr. Demuth held the positions of General Manager at Integrated Genomics. He has a long track record in the management of new ventures including holding the position of CEO of Cerulean Enterprises. Mr. Demuth has a BSc in Psychology from the University of Iowa and was a co-founder of the internationally-recognized Chicago Teacher Academy for Mathematics and Science with the Nobel Laureate Physicist, Leon Lederman. He is the author of 13 scientific papers.
ALEXANDER KHVAT, Ph.D. Senior Director of Research & Development
Prior to joining ChemDiv, Dr. Khvat held the positions of Senior Research Scientist at the Ukrainian Scientific Research Institute for Pharmacology and Therapy of Endocrine Disorders and Post-Doctoral Research Scientist at the University of Nottingham, UK. He has a nine year track-record in custom synthesis and spectroscopic investigations of organic compounds including completion of over fifty custom and medicinal chemistry projects with major pharmaceutical and biotech companies. Dr. Khvat has a Ph.D. in organic chemistry from Kharkov State University and is the author of 26 scientific papers and 20 patents.
ALEXEI PUSHECHNIKOV, Ph.D.
Vice President, Discovery Platforms
Dr. Pushechnikov has over 15 years of research experience in academy and biotech industries as well as managerial experience from various contract research and manufacturing organizations. Dr. Pushechnikov has a background in chemical engineering and a PhD in synthetic organic chemistry, which allowed him to acquire broad practical experience in managing interdisciplinary projects with emphasis on chemical biology, medicinal chemistry and process research for pharmaceutical and biotech companies. His achievements related to various aspects of drug discovery process are reflected in 36 peer-reviewed publications and patents.